Along with the decreasedIGF2BP3 mRNA levels, there was also a significant down-regulation of PD-L1 mRNA expression, indicating that IGF2BP3 may participate in the immune response of bladder cancer through PD-L1. The gene discussed is IGF2BP3; the disease is urinary bladder cancer.